Refrences
1. Kashani-Sabet M, McMillan A, Zackheim HS. A modified staging classification for cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology. 2001;45(5):700-6.
2. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-85.
3. Wood DE. National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening. Thoracic surgery clinics. 2015;25(2):185-97.
4. Prince HM, Duvic M, Martin A, Sterry W, Assaf C, Straus DJ. Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sezary syndrome receiving placebo. Journal of the American Academy of Dermatology. 2012;67(5):867-75.
5. Talpur R, Bassett R, Duvic M. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome. British Journal of Dermatology. 2008;159(1):105-12.
6. Sorrells T, Pratt L, Newton J, Graham S, Ryan M. Spontaneous regression of granulomatous mycosis fungoides in an HIV positive patient. Journal of the American Academy of Dermatology. 1997;37(5):876-80.
7. Pasin F, Mascalchi Calveri M, Calabrese A, Pizzarelli G, Bongiovanni I, Andreoli M, et al. Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma. Acta Biomed. 2020;91(3):ahead of print.
8. Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. The Journal of infectious diseases. 2020;221(11):1762-9.
9. Snijder J, Mihyawi N, Frolov A, Ewton A, Rivero G. Spontaneous remission in diffuse large cell lymphoma: a case report. Journal of medical case reports. 2019;13(1):1-7.
10. Musto P, D’Arena G, Meillo L, Cascavilla N, Ladogana S, Carotenuto M. SPONTANEOUS REMISSION IN ACUTE MYELOID LEUKAEMIA: A ROLE FOR ENDOGENOUS PRODUCTIONOF TUMOUR NECROSIS FACTOR AND INTERLEUKIN‐2? British journal of haematology. 1994;87(4):879-80.
11. Santos JM, Cervera-Carrascon V, Havunen R, Zafar S, Siurala M, Sorsa S, et al. Adenovirus coding for interleukin-2 and tumor necrosis factor alpha replaces lymphodepleting chemotherapy in adoptive T cell therapy. Molecular therapy. 2018;26(9):2243-54.
12. Pasin F, Calveri MM, Pizzarelli G, Calabrese A, Andreoli M, Bongiovanni I, et al. Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma. Acta Bio Medica: Atenei Parmensis. 2020;91(3):e2020047.